Stuttgart - Delayed Quote EUR
Clearside Biomedical, Inc. (CLM.SG)
0.6500
+0.0200
+(3.17%)
As of 8:01:08 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,764
1,664
8,226
1,327
29,575
Cost of Revenue
397
149
355
204
0
Gross Profit
3,367
1,515
7,871
1,123
29,575
Operating Expense
29,245
30,397
32,715
31,400
30,202
Operating Income
-25,878
-28,882
-24,844
-30,277
-627
Net Non Operating Interest Income Expense
-8,772
-8,317
-7,641
-2,670
0
Other Income Expense
4,553
2,847
1,719
669
1,003
Pretax Income
-30,097
-34,352
-32,485
-32,947
376
Net Income Common Stockholders
-30,812
-34,352
-32,485
-32,947
376
Diluted NI Available to Com Stockholders
-30,812
-34,352
-32,485
-32,947
376
Basic EPS
-0.41
-0.47
-0.53
-0.55
0.01
Diluted EPS
-0.41
-0.47
-0.53
-0.55
0.01
Basic Average Shares
75,570.5020
73,803.3480
61,806.9590
60,204.8620
58,491.9860
Diluted Average Shares
75,570.5020
73,803.3480
61,806.9590
60,204.8620
59,906.6020
Total Operating Income as Reported
-25,878
-28,882
-24,844
-30,277
-627
Total Expenses
29,642
30,546
33,070
31,604
30,202
Net Income from Continuing & Discontinued Operation
-30,812
-34,352
-32,485
-32,947
376
Normalized Income
-30,812
-34,352
-32,485
-32,947
376
Interest Income
1,277
1,462
1,719
669
--
Interest Expense
10,049
9,779
9,360
3,339
0
Net Interest Income
-8,772
-8,317
-7,641
-2,670
0
EBIT
-20,048
-24,573
-23,125
-29,608
376
EBITDA
-19,765
-24,347
-23,058
-29,463
554
Reconciled Cost of Revenue
397
149
355
204
0
Reconciled Depreciation
283
226
67
145
178
Net Income from Continuing Operation Net Minority Interest
-30,812
-34,352
-32,485
-32,947
376
Normalized EBITDA
-19,765
-24,347
-23,058
-29,463
554
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/9/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade